<DOC>
	<DOCNO>NCT00746733</DOCNO>
	<brief_summary>The purpose study determine take Vyvanse Prilosec OTC Adderall XR Prilosec OTC change quickly drug absorb body and/or change much drug absorb body .</brief_summary>
	<brief_title>Vyvanse Adderall XR Given Alone Combination With Prilosec OTC</brief_title>
	<detailed_description />
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Adderall</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>1 . Healthy volunteer , age 18 45 inclusive time consent . 2 . Male , nonpregnant , nonlactating female 3 . Female subject must negative serum beta Human Chorionic Gonadotropin ( HCG ) pregnancy test Screening , negative urine pregnancy test Day 1 check clinic day first dose investigational product . 4 . Body Mass Index ( BMI ) 20.0 30.0 kg/mÂ² inclusive . This inclusion criterion assess first screen visit . 5 . Satisfactory medical assessment significant relevant abnormality medical history , physical examination ( PE ) , vital sign laboratory evaluation 6 . Normal clinically insignificant Screening ECG finding assess Investigator . 7 . Ability swallow investigational product . 1 . Current recurrent disease could affect action , absorption disposition investigational product , could affect clinical laboratory assessment . 2 . Current relevant previous history physical psychiatric illness , medical disorder may require treatment make subject unlikely fully comply requirement study complete study , condition present undue risk investigational product study procedure . 3 . Significant illness , judge Investigator , within 2 week first dose investigational product . 4 . History significant anxiety , tension agitation assess Investigator . 5 . History current diagnosis glaucoma . 6 . History seizure disorder ( infantile febrile seizure ) , tic disorder current diagnosis and/or know family history Tourette 's Disorder . 7 . History symptomatic cardiovascular disease , advanced arteriosclerosis , structural cardiac abnormality , cardiomyopathy , serious heart rhythm abnormality , coronary artery disease , transient ischemic attack stroke serious cardiac problem may place increased vulnerability sympathomimetic effect stimulant drug . 8 . History control uncontrolled hypertension rest sit systolic blood pressure &gt; 139mmHg diastolic blood pressure &gt; 89mmHg . 9 . Known family history sudden cardiac death ventricular arrhythmia . 10 . Currently consider suicide risk , previously make suicide attempt prior history , currently demonstrate suicidal ideation . 11 . Current use medication ( include prescription , counter [ OTC ] , herbal homeopathic preparation ) exception hormonal replacement therapy hormonal contraceptive ( Current use define use within 14 day first dose investigational product ) . 12 . Use medication know inhibit induce CYP450 enzymes responsible metabolism investigational product within 14 day first dose investigational product . 13 . Known suspected intolerance hypersensitivity investigational product ( ) , closely related compound state ingredient . 14 . History alcohol substance abuse within last year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Drug</keyword>
	<keyword>Interaction</keyword>
	<keyword>Study</keyword>
</DOC>